Max Robotics — Global Service Robot Directory + US Certification

About

Nicolas Alvarez-Garrido is a leading researcher in surgical oncology and health economics, with a focused expertise in minimally invasive pancreatic surgery. His major contribution lies in rigorously evaluating the cost-effectiveness of robotic versus laparoscopic techniques, directly addressing a critical gap in surgical decision-making. As the lead author of the landmark national prospective trial ROBOCOSTES, he demonstrated that while robotic distal pancreatectomy offers comparable clinical outcomes, its higher costs require careful consideration for widespread adoption. This work, published in 2024 and already garnering over 10 citations, has become a foundational reference for hospitals and policymakers balancing innovation with resource allocation. Alvarez-Garrido’s research bridges the gap between surgical precision and economic sustainability, providing evidence-based guidance for the future of minimally invasive surgery. His meticulous approach to comparative effectiveness research positions him as a key voice in the ongoing debate over the value of robotic surgery, making his findings essential reading for surgeons, hospital administrators, and health economists alike.